StockData
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. (ARQT) bonds

ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30403% above fair value
$27.33+0.18 (+0.66%)

Close on Nov 17, 2026Market cap $3.44BP/E 124.2Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$108.90M
$6.95M due within a year
Net debt
$74.78M
After $34.12M of cash
Implied interest rate
11.18%
FY2025 interest ÷ average debt
Interest coverage
-1.0×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Arcutis Biotherapeutics's 10-Q for the period ended Jun 30, 2026

IssueCouponCarrying value
Loan agreement7.45%$100.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?